Decode Age, a Bengaluru-based longevity research company, raised around $150,000 in October 2021 through multiple angel investors and now, in 2022, aims to raise close to $500,000 through strategic partners, and VCs. 

Started in 2021 as a bootstrap with $125,000, the three founders of Decode Age – Darshit Patel, Parth Amin and Rakesh Somani, ventured into longevity research, with an aim to identify, innovate, build, and create awareness for what is going to change healthcare in the coming times.

Their first round of investment, which totalled $150,000 in October 2021, enabled them to establish a genomics laboratory, initiate and launch a gut microbiome test, and leverage cutting-edge technologies unmatched in India to forecast early symptoms of ageing and age-related diseases. The founders also built a range of preventive products focused on targeting molecular and cellular aspects of ageing.

Decode Age is now set to raise $500,000 through strategic partners, and VCs so as to scale up their gut microbiome test and preventive care range of products. A part of the funds would also be utilised to expand the geographical market reach, funding for clinical research on supplements, develop a technology platform for end-to-end longevity as a service, marketing and spread awareness about longevity science, make an effective supply chain, and create tech for efficient user journey.